Amphastar Pharmaceuticals, Inc. (AMPH): Depreciation & Amortization
Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$25.74M
Year ended 2023-12-31
+41.8%
3-year compound annual growth
+33.6%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $25.74M | +104.3% | 2024-02-29, From 2023-01-01 |
| 2022-12-31 | $12.60M | +23.2% | 2024-02-29, From 2022-01-01 |
| 2021-12-31 | $10.22M | +13.2% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $9.03M | +27.9% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $7.06M | +16.6% | 2022-03-11, From 2019-01-01 |
| 2018-12-31 | $6.05M | -5.7% | 2021-03-15, From 2018-01-01 |
| 2017-12-31 | $6.42M | n/a | 2020-03-16, From 2017-01-01 |